News

Medical Physics Consultants, Inc

X-ray Attenuating Hand Cream

BloXR’s “Ultra Blox X-ray Attenuating Cream” uses a ceramic powder that contains Bismuth Oxide to reduce hand exposures 50 – 85%. The product is to be released 09/09/13. 08/15/13

More

NRC Changes Fingerprinting Address

Those involved with T&R officials and whole blood irradiators need to note that there has been a change in address for submitting fingerprints to the NRC.

More

Radium-223 Gets FDA Approval

Radium-223 injectable prostate cancer therapy has gained FDA approval as “Xofigo” Bayer Pharmaceutical announced. 05/16/13

More

Spectrum Dynamics Sold

Spectrum Dynamics, makers of the D-SPECT camera system has been sold to Biosensors International Group of Singapore.

More

NRC Shortens “Recentness of Training”

As of 3/7/13 the NRC has issued a revised approved “Board Certification” listing for medical uses. It notes a limit of acceptance of only four(4) years from the date of issue only for new American Board of Radiology Certified physicians and physicists. It was previously seven(7) years. 03/19/13

More

SNMMI to Release “Choosing Wisely Information

The SNMMI will release on 2/21/13 a pamphlet noting “Five Things Physicians and Patients Should Question”. These are targeted, evidence-based recommendations to assist in the proper selection of imaging procedures. 2/18.13

More

NRC Rules Ra-223 is 35.300

The NRC has finalized that Ra-223 “Alpharadin” will be ruled a 35.300 radiopharmaceutical and for those institutions already licensed under this section with AU granted full 35.300 status – No Amendment needed.

More